<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; News by Subject</title>
	<atom:link href="http://www.bioscreening.net/category/news/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Prous Institute Presents Innovative Approach to Drug Discovery</title>
		<link>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/</link>
		<comments>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/#comments</comments>
		<pubDate>Tue, 03 Mar 2009 07:44:41 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/</guid>
		<description><![CDATA[BARCELONA, February 26 /PRNewswire/ &#8212; Prous Institute for Biomedical Research today presented its strategies for drug discovery on its newly designed website (http://www.prousresearch.com). A large computational project with basic research support and broad disease coverage is being developed at Prous Institute under the broad-based Epistemic Drug Discovery(R) project. President and C.E.O. of the Institute, Dr. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/03/03/prous-institute-presents-innovative-approach-to-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease</title>
		<link>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/</link>
		<comments>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/#comments</comments>
		<pubDate>Mon, 01 Dec 2008 16:59:49 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/</guid>
		<description><![CDATA[Combination of Proprietary Drug Targets and Unique Technologies to Create Range of New Therapeutic Antibodies MUNICH, GERMANY &#8212; (Marketwire) &#8212; 11/26/08 &#8212; MorphoSys AG (FSE: MOR; Prime StandardSegment, TecDAX) and Galapagos NV (Euronext: GLPG) announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/12/01/morphosys-and-galapagos-enter-alliance-to-co-develop-novel-therapeutic-antibodies-in-bone-and-joint-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IPR story 12- Patenting a mere idea</title>
		<link>http://www.bioscreening.net/2008/11/26/ipr-story-12-patenting-a-mere-idea/</link>
		<comments>http://www.bioscreening.net/2008/11/26/ipr-story-12-patenting-a-mere-idea/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 18:14:55 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Biotech & Pharma Law]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Subject]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/ipr-story-12-patenting-a-mere-idea/</guid>
		<description><![CDATA[Jaidev had joined a leading Pharmaceutical Research Institute in India, for his Ph.D work. He reviewed his research plan thoroughly and also searched patents. Based on discussions with his guide, he formulated a very innovative research plan, pertaining to development of a new screening method for diabetic compounds. He started his work and after nearly [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/ipr-story-12-patenting-a-mere-idea/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The difficulties of Cushingâ€™s syndrome</title>
		<link>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/</link>
		<comments>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:55:25 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Cushingâ€™s syndrome]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/</guid>
		<description><![CDATA[Diagnosing and treating Cushingâ€™s syndrome is sometimes just as difficult as it was 70 years ago. For as long as it has been described, Cushingâ€™s syndrome has presented physicians with a problem. Harvey Cushing first described it in 1932, and the diagnosis, differential diagnosis and treatment of Cushingâ€™s have remained a major challenge for endocrinologists [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/the-difficulties-of-cushing%e2%80%99s-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot</title>
		<link>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/</link>
		<comments>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:38:30 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/</guid>
		<description><![CDATA[Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/nanion-increases-throughput-and-cuts-costs-with-a-new-industrial-96-channel-patch-clamp-screening-robot-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A new approach to functional screening of siRNA knockdown</title>
		<link>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</link>
		<comments>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:37:56 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</guid>
		<description><![CDATA[KINGSTON, England, Nov. 25, 2008-Guava Technologies, Inc. presented at the recent Molecular Targets &#038; Cancer Therapeutics Symposium* information on their recent advancements that describe an experimental methodology and the new GuavaÂ® Simplicity Analysis Software which exploit the advantages of plate based flow technology. These technological improvements result in an overall process that can significantly expedite [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Galapagos and Merck Serono Enter New Collaboration Agreements</title>
		<link>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</link>
		<comments>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 20:30:09 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/</guid>
		<description><![CDATA[Mechelen, Belgium; 18 November 2008 â€“ Galapagos NV (Euronext: GLPG) announced today new collaboration agreements with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. Total value of the contracts for Galapagos is â‚¬1.1 million over one year. Galapagosâ€™ service division BioFocus DPI will provide SoftFocusÂ© compounds for use in Merck Seronoâ€™s drug discovery programs. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/galapagos-and-merck-serono-enter-new-collaboration-agreements/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Green protein inhibits Alheimer&#8217;s, CSIRO scientists find</title>
		<link>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</link>
		<comments>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:42:19 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</guid>
		<description><![CDATA[BY NYSSA SKILTON MEDICAL REPORTER 18/11/2008 CSIRO scientists have developed a way to screen for compounds that can inhibit the progression of Alzheimer&#8217;s disease. The system involves using live yeast and a protein called Abeta fused to a fluorescent green protein, which comes from jellyfish. The scientists, working within CSIRO&#8217;s Preventive Health Flagship, published their [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists seek out Alzheimer&#8217;s enemies</title>
		<link>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</link>
		<comments>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:24:14 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</guid>
		<description><![CDATA[CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimerâ€™s disease. In a paper published in the Journal of Alzheimerâ€™s Disease, folate is shown to be beneficial in the screening system. Lead author, CSIROâ€™s Dr Ian Macreadie says folate [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GEN Reports on the Trend Toward Predictive Toxicogenomics</title>
		<link>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</link>
		<comments>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 17:00:22 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</guid>
		<description><![CDATA[NEW ROCHELLE, N.Y., Nov 19, 2008 /PRNewswire via COMTEX/ &#8212; Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems, reports Genetic Engineering &#038; Biotechnology News (GEN). They are especially interested in figuring out a new compound&#8217;s mechanism of action [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ebola Virus Disarmed By Excising A Single Gene</title>
		<link>http://www.bioscreening.net/2008/02/05/ebola-virus-disarmed-by-excising-a-single-gene/</link>
		<comments>http://www.bioscreening.net/2008/02/05/ebola-virus-disarmed-by-excising-a-single-gene/#comments</comments>
		<pubDate>Tue, 05 Feb 2008 19:02:00 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/02/05/ebola-virus-disarmed-by-excising-a-single-gene/</guid>
		<description><![CDATA[The deadly Ebola virus, an emerging public health concern in Africa and a potential biological weapon, ranks among the most feared of exotic pathogens. Due to its virulent nature, and because no vaccines or treatments are available, scientists studying the agent have had to work under the most stringent biocontainment protocols, limiting research to a [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/02/05/ebola-virus-disarmed-by-excising-a-single-gene/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hydra Biosciences and Pfizer Global Research &amp; Development Sign Collaboration Agreement</title>
		<link>http://www.bioscreening.net/2007/08/01/hydra-biosciences-and-pfizer-global-research-development-sign-collaboration-agreement/</link>
		<comments>http://www.bioscreening.net/2007/08/01/hydra-biosciences-and-pfizer-global-research-development-sign-collaboration-agreement/#comments</comments>
		<pubDate>Wed, 01 Aug 2007 15:53:19 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/08/01/hydra-biosciences-and-pfizer-global-research-development-sign-collaboration-agreement/</guid>
		<description><![CDATA[CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Hydra Biosciences announced today that it has signed a collaboration agreement with Pfizer Global Research &#038; Development. The collaboration will be focused on TRPV3 antagonist product candidates for pain. The Transient Receptor Potential (TRP) channel family comprises a novel group of non-selective cation channels that are distinct from classical voltage gated ion channels. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/08/01/hydra-biosciences-and-pfizer-global-research-development-sign-collaboration-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protected: BIT&#8217;s 4th Annual Congress of International Drug Discovery Science &amp; Technology 2006 (IDDST-2006)</title>
		<link>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/</link>
		<comments>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/#comments</comments>
		<pubDate>Thu, 16 Feb 2006 03:14:19 +0000</pubDate>
		<dc:creator>iddst2006</dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reagents]]></category>
		<category><![CDATA[South America]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/</guid>
		<description><![CDATA[There is no excerpt because this is a protected post.]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/02/15/bits-4th-annual-congress-of-international-drug-discovery-science-technology-2006-iddst-2006/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lab901: itâ€™s in the box</title>
		<link>http://www.bioscreening.net/2005/06/03/36/</link>
		<comments>http://www.bioscreening.net/2005/06/03/36/#comments</comments>
		<pubDate>Fri, 03 Jun 2005 16:20:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[News by Subject]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/06/07/36/</guid>
		<description><![CDATA[Rising Scottish technology company, Lab901 has shipped the first of its pioneering ScreenTape systems, only days after receiving a crucial Â£1 million in third-round equity funding, led by Archangel Informal Investments. The first ScreenTape system has been delivered to the Scottish Centre for Genomic Technology and Informatics (SCGTI) at the University of Edinburgh. This significant [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/06/03/36/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Corning ANNOUNCES NEW CorningÂ®CellBINDÂ® Surface PRODUCTS for Enhanced Cell Attachment</title>
		<link>http://www.bioscreening.net/2005/05/05/corning-announces-new-corning%c2%aecellbind%c2%ae-surface-products-for-enhanced-cell-attachment/</link>
		<comments>http://www.bioscreening.net/2005/05/05/corning-announces-new-corning%c2%aecellbind%c2%ae-surface-products-for-enhanced-cell-attachment/#comments</comments>
		<pubDate>Thu, 05 May 2005 16:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/05/10/corning-announces-new-corning%c2%aecellbind%c2%ae-surface-products-for-enhanced-cell-attachment/</guid>
		<description><![CDATA[Surface Treatment Technology Now Available on Multiple Well Plates, Cell Culture Style Dishes and Expanded Surface Flask 

Acton, Massachusetts, May 5, 2005 - Corning Life Sciences, a global supplier of scientific laboratory and drug discovery products for more than 90 years, today announced the addition of 6, 12, and 24 well plates, 35, 60, and 100mm style dishes and the 235 cm2 expanded surface flask to the new CorningÂ® CellBINDÂ® Surface family of products. The Corning CellBIND Surface represents the first innovation in cell culture surface treatment in more than 20 years. The unique surface improves consistency and provides more uniform cell attachment across well, dish and flask bottoms, allowing for higher cell yields. ]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/05/05/corning-announces-new-corning%c2%aecellbind%c2%ae-surface-products-for-enhanced-cell-attachment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

